Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response

Contemporary chemotherapy for childhood acute lymphoblastic leukemia (ALL) is risk-adapted based on clinical features, leukemia genomics and minimal residual disease (MRD); however, the pharmacological basis of these prognostic variables remains unclear. Analyzing samples from 805 children with newl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shawn H. R., Yang, Wenjian, Gocho, Yoshihiro, John, August, Rowland, Lauren, Smart, Brandon, Williams, Hannah, Maxwell, Dylan, Hunt, Jeremy, Yang, Wentao, Crews, Kristine R., Roberts, Kathryn G., Jeha, Sima, Cheng, Cheng, Karol, Seth E., Relling, Mary V., Rosner, Gary L., Inaba, Hiroto, Mullighan, Charles G., Pui, Ching-Hon, Evans, William E., Yang, Jun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873558/
https://www.ncbi.nlm.nih.gov/pubmed/36604538
http://dx.doi.org/10.1038/s41591-022-02112-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873558/
https://www.ncbi.nlm.nih.gov/pubmed/36604538
http://dx.doi.org/10.1038/s41591-022-02112-7

Ejemplares similares